Menu
Windlas Biotech Ltd, founded in 2001, is one of India’s leading contract development and manufacturing organisations (CDMO) for pharmaceutical formulations. From product discovery to product development, licencing, and commercial manufacturing of generic products, including complex generics, the company provides a wide range of CDMO services.
It additionally sells its own marked items in the exchange generics and OTC business sectors. The organization’s present spotlight is on the dispatch of intricate conventional items in the ongoing remedial classification identified with way of life related problems. The organization works in three portions: 1. CDMO items and administrations, 2. homegrown exchange generics, and 3. over-the-counter (OTC) market (nutraceutical and wellbeing supplement items).
Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are a few of Windlas Biotech’s marquee clients. Its manufacturing facilities are located in Dehradun, and it has an established working capacity of 7,063.83 million tablets/cases and 54.46 million units.
| Subscription Dates | 4 – 6 August 2021 |
| Price Band | INR448 – 460 per sshare |
| Fresh issue | INR165 crore |
| Offer For Sale | 5,142,067 shares (INR230.36 – 236.53 crore) |
| Total IPO size | INR395.36 – 401.53 crore |
| Minimum bid (lot size) | 30 shares |
| Face Value | INR5 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
FY2019 | FY2020 | FY2021 | ||
Revenue | 311.5 | 331.3 | 430.7 | |
Expenses | 284.2 | 299.2 | 387.2 | |
Net income | 63.7 | 16.0 | 15.9 | |
Margin (%) | 20.4 | 4.8 | 3.7 |
Earnings Per Share (EPS): INR8.70
Price/Earnings (PE ratio): 51.49 – 52.87
Return on Net Worth (RONW): 18.19%
Net Asset Value (NAV): INR109.36 per share
Date | Windlas Biotech IPO GMP | Kostak | Subject to Sauda |
14 August 2021 | INR80 | – | – |
13 August 2021 | INR80 | – | – |
12 August 2021 | INR75 | – | – |
11 August 2021 | INR60 | – | – |
10 August 2021 | INR70 | – | – |
Company Name
Listed On
Issue Price
Listing Day Close
Listing Day Gain
Windlas Biotech Limited
Aug 16, 2021
460
406.7
-11.59
NSE : WINDLAS
BSE :543329
ISIN CODE : INE0H5O01029
Angel Broking – Subscribe
BP Wealth – Subscribe
Canara Bank Securities –
Choice Broking – Subscribe for long term
Elite Wealth – Listing gains
Hem Securities – Subscribe
ICICIdirect – Unrated
Marwadi Financial Services – Subscribe
Ventura Securities – Subscribe
IPO Opening Date: 4 August 2021
IPO Closing Date: 6 August 2021
Finalisation of Basis of Allotment: 11 August 2021
Initiation of refunds: 12 August 2021
Transfer of shares to
demat accounts: 13 August 2021
Listing Date: 16 August 2021
Windlas Biotech Limited
705-706, Vatika Professional Point, Sector-66, Golf Course Extension Road,
Gurgaon 122 001, Haryana
Phone: +91 124 2821030
Email: grievance@windlasbiotech.com
Website: www.windlasbiotech.com
Link Intime India Private Limited
C-101, 1st Floor,247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: windlas.ipo@linkintime.co.in
Website: www.linkintime.co.in
Category | Shares offered | Subscription (no. of times, at 5 PM) | ||
Day 1 | Day 2 | Day 3 | ||
QIB | 17,23,700 | 0.00 | 0.04 | 24.40 |
NII | 13,23,766 | 0.34 | 1.11 | 15.73 |
Retail | 30,88,786 | 6.12 | 13.40 | 24.10 |
|
|
|
|
|
Total | 61,36,252 | 3.15 | 6.99 | 22.38 |
Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per equity share. The minimum order quantity is 30 Shares.
.The initial public offering (IPO) begins on Aug 4, 2021 and ends on Aug 6, 2021.The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the BSE and NSE.
The Windlas Biotech IPO opens on Aug 4, 2021 and closes on Aug 6, 2021.
Windlas Biotech IPO lot size is 30 Shares and the minimum order quantity is 30 Shares.
Windlas Biotech IPO applications can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications..Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.
The Basis of Allotment for Windlas Biotech IPO will be done on Aug 11, 2021, and the allotted shares will be credited to your demat account by Aug 13, 2021. Check the Windlas Biotech IPO allotment status.
The Windlas Biotech IPO listing date is on Monday, August 16, 2021.
© 2021 All rights reserved